Detailed answers about ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE, including incorporation, status, business activity, and accounts information.
When was ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE founded?
ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE was officially incorporated on 19 July 2013 and is registered under company number 08617354. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE?
ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE do?
ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE operates in the following sector: 74909 - Other professional, scientific and technical activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE's registered address?
The registered office address of ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE is SUITE 213, BOUNDARY HOUSE, BOSTON MANOR ROAD, LONDON, ENGLAND, W7 2QE. This is the official address filed with Companies House for legal and statutory correspondence.
Is ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE financially stable?
The most recent accounts for ALPHA - SCIENTISTS IN REPRODUCTIVE MEDICINE were made up to 31 July 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 April 2026.